STEP-programme S-candiaT-ransplant kidney E-xchange P-rogramme (STEP) Version 1.8

Similar documents
Living Donor Paired Exchange (LDPE)

UCLA Kidney Exchange. An option for patients with incompatible living donors

Virtual Crossmatch in Kidney Transplantation

Organ Procurement and Transplantation Network

Minutes Tissue Typers Meeting Aarhus, 21st September 2018

NHSBT Board July Update on UK Living Kidney Sharing Scheme

A Guide to Better Living

Paired Donation. Andrew Bradley Rachel Johnson Joanne Allen Susan V Fuggle. Cambridge University NHS Hospitals NHS Foundation trust

6/19/2012. Who is in the room today? What is your level of understanding of Donor Antigens and Candidate Unacceptables in KPD?

The Kidney Exchange Problem

Mary Keogan, on Mary behalf Keogan of all in NHISSOT On behalf of all in NHISSOT. 4th April 2014

The New Kidney Allocation System (KAS) Frequently Asked Questions

Donation and Transplantation Kidney Paired Donation Program Data Report

Barriers to Transplantation

Oxford Transplant Centre. Live donor kidney transplantation what if we are not a match?

The Acceptable Mismatch program of Eurotransplant.

TA L K I N G A B O U T T R A N S P L A N TAT I O N

EZER MIZION PROCEDURES FOR TRANSPLANT CENTERS AND COOPERATIVE REGISTRIES

Donation & Transplantation Interprovincial Programs Report

Chapter 10. Histocompatibility Testing

New Zealand Kidney Allocation Scheme

New Ways to Tackle a Growing Health Care Dilemma - ESRD

Evaluation of Two New Antibody Detection Techniques in Kidney Transplantation. Doctoral Thesis. Dr. Petra Gombos

Candidates about. Lung Allocation Policy. for Transplant. Questions & A n s we r s TA L K I N G A B O U T T R A N S P L A N TAT I O N

Calculation Tables. Olerup SSP Kits without Taq Polymeras

Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation

Organ transplantation in Bulgaria

UEMS & EBS: DIVISION OF TRANSPLANT SURGERY

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME

Calculation Tables. Olerup SSP Kits without Taq Polymeras

Update to the Human Leukocyte Antigens (HLA) Equivalency Tables

Summary of Significant Changes. Policy

Frequently Asked Questions about Kidney Transplantation

Documentation of Changes to EFI Standards: v 5.6.1

The MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK

User Manual PAIRED KIDNEY. Australian Paired Kidney Exchange (AKX) Programme. Index - Contents. Australian EXCHANGE PROGRAMME AKX AKX

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

OPTN/UNOS Histocompatibility Committee Report to the Board of Directors November 12-13, 2014 St. Louis, MO

About kidney transplant care in New Zealand

Expanding Candidate and Deceased Donor HLA Typing Requirements to Provide Greater Consistency Across Organ Types

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

Green Light to Transplant: A Stepwise Approach

Keeping your options open. Transplant In Center Hemodialysis Home Hemodialysis Peritoneal dialysis No dialysis

Basel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva

KIDNEY EXCHANGE PROGRAMMES IN EUROPE. Position Paper of the. European Committee on Organ Transplantation (CD-P-TO) of the Council of Europe

Kidney Exchange Problem

Blood Component Testing and Labeling

POSITION STATEMENT ON THE PROPOSAL FOR A GLOBAL KIDNEY EXCHANGE

Chapter 10. Histocompatibility Testing

Why so Sensitive? Desensitizing Protocols for Living Donor Kidney Transplantation

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

Utilizing List Exchange and Nondirected Donation through Chain Paired Kidney Donations

The number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275

9/30/2016. Chris E. Freise, MD Professor of Surgery UCSF Transplant Division

ASHI Proficiency Testing Program Summary Report. Survey 2013-HT1 / HLA Typing

OPTN/UNOS Policy Notice Review of HLA Tables (2016)

The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033

Kidney Exchange: Past, Present, and Potential Future

KIDNEY TRANSPLANT - A TREATMENT OPTION

Highly Sensitized Patient Registry: Update and Successes

Histocompatibility Evaluations for HSCT at JHMI. M. Sue Leffell, PhD. Professor of Medicine Laboratory Director

National Transplant Guidelines

DEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS

Answers to Your Questions about a Change in Kidney Allocation Policy What you need to know

Guide to Transplantation and Living Donation

Summary of Significant Changes. Policy

Kidney Transplant Activity New Zealand

Allocation of deceased donor kidneys. Phil Clayton NSW Renal Group 14 June 2012

Organ Donation. United States and European Union Perspective

Founded 1969 by the Nordic Council of Ministers

Who are UNOS and the OPTN? What is the lung allocation system?

Transfusion support in Transplantation

Role of NMDP Repository in the Evolution of HLA Matching and Typing for Unrelated Donor HCT

Desensitization in Kidney Transplant. James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver

Human Leukocyte Antigens and donor selection

Management of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale

Histocompatibility. HLA Serologic Typing (Class I/II) ABO, HLAS, HLAS Surveys & Anatomic Pathology Education Programs

Transplantation in 2012:

Pilot on inclusion of a case report in the external proficiency testing program

Types of living donor transplants

Getting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn:

Glossary. Anesthesiologist A doctor who puts you or parts of your body to sleep during surgery.

Georgia Regents. Kidney and Pancreas Transplant Program. Welcome!

Transplant Applications of Solid phase Immunoassays Anti HLA antibody testing in solid organ transplantation

Patient Education Class

Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005)

Kidney, Pancreas and Liver Allocation and Distribution

Clinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017

THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION

OPERATIONS AND PATIENT SERVICES USER GUIDE. Procedures for transplant centres and international establishments

Kidney Transplant Activity New Zealand

Dictionary of Organ Donation and Transplantation Terms

The Kidney Allocation System Changed in a Substantive Way on December 5, Your Patients Have Been, and Will Be, Affected by These Changes

Living Donor Kidney Transplant Education Manual

UW MEDICINE PATIENT EDUCATION. Kidney Transplant. A treatment option for kidney disease. Kidney Transplant

Chest x-ray Cardiovascular tests (EKG, echocardiogram, angiogram, stress test) Upper and lower G.I. (gastrointestinal) tests Blood tests

WORLD HEALTH ORGANIZATION. Human organ and tissue transplantation

Current strategies to kidney allocation

Corporate Medical Policy

Transcription:

STEP-programme S-candiaT-ransplant kidney E-xchange P-rogramme (STEP) Version 1.8 June 12, 2017

General guidelines Purpose To increase the likelihood of offering a suitable kidney graft to immunized (HI) recipients who are crossmatch positive against their living donor or AB0-incompatible, thus reducing their time on the waiting list. Success criteria Programme launched Planned exchange cycles are executed without major obstacles Survival of grafts comparable to (or better than) than in other immunized patients with similar PRA-levels Donor and recipient satisfaction Acceptance criteria Transplants centres: Must be Organ Procurement and Transplantation Centre within Scandiatransplant Must have a designated contact for the Program Must agree to abide the rules for the program Recipient criteria: Adult patients that are eligible (or accepted to the waiting list) for a kidney transplant and are receiving care at a transplant centre within the Nordic countries can join. Patients do not have to be on dialysis to join. Patients must have a crossmatch positive (and therefore unsuitable) but otherwise medically acceptable living donor who is willing to donate a kidney within the STEP programme. It is also possible for a center to include a ABO-incompatible couple into the programme. The couple could be included for one or several match runs

and if no match is found it could be transplanted through the ABOincompatible programme. Donor criteria: (recommended under normal circumstances, may be discussed in specific cases) The donor must be fully informed and willing to take part in an exchange. Like any living donation program, all potential donors are required to complete an extensive medical and psychological evaluation to decide if they are acceptable as kidney donors. A GFR above 80 ml/min/1.73m2 measured by a tracer (not calculated) Sitting untreated BP <140/90 mmhg or 24 h BP <130/80 mmhg. No Diabetes. No Proteinuria No specific information on donor identity can be given to the recipient but general medical donor information may be given during the consent process. All donors will receive a SCTP number that can be used for traceability in the recipient medical files. Both the donor and the recipient in both (all) exchange pairs need to be accepted by both Transplant teams involved (for important factors such as age, kidney function, prior medical conditions, anatomical details etc.) Donors must be reported to the SCTP living donor database and followed up after donation according to local and best-practice guidelines Informed Consent Requirements For candidates: A transplant centre representative must review the components of the Program with the candidate separately from the paired potential living donor. After review, the transplant centre will ask the candidate to sign a consent form. If the candidate chooses to accept a shipped kidney, the transplant centre must have a signed consent form showing that the candidate has been

informed of the potential risks of shipping a kidney. The consent will be valid for one year. For potential living donors: For any exchange, the Transplant Hospital evaluating the potential donor is responsible for receiving informed consent from potential donors (including the risk that surgery may not occur due to unforeseen events in the operating room). The consent will be valid for one year. Match runs: The recipient will remain on the deceased donor list even if the recipient and donor joins the STEP-programme. If the donor-recipient pair are found to have a potential exchange pair after a match run, the recipients will be temporarily deactivated on the waiting list. When a paired exchange has taken place they will be removed from the waiting list. If the paired exchange is cancelled they will be reactivated on the waitinglist. Match runs will be performed at regular intervals and the time interval between match runs will be decided dependent of the number of participants in the program. Coordination Coordinating teams from both (all) Transplantation units involved need to communicate, plan and coordinate all required exchange activities (such as surgical operations, communication, transport etc.) in good advance. Operative procedure, preservation and transportation: In a kidney exchange both (all) donor operations will start simultaneously. Before start of the surgery and before vascular clamping and organ removal telephone calls will take place between the two (all) operations rooms to verify and synchronize activities. The donor kidneys will be preserved according to agreement and transported to the recipient centre as soon as possible. The start of the donor operations could be adjusted to fit regular flights. Compensation: All costs for both recipient and donor (including necessary immunological

work-up etc.) are covered by the local Transplantation unit. Costs for transport is covered by the receiving Transplantation unit. Immunological testing of donor recipient pairs HLA Typing: both recipient and donors must be typed for HLA A,B,C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1 and DPB1. The resolution should be at second field level but common null alleles such as DRB4*01:03:01:02N must be identified. Information about both the genomic assignment and the corresponding serological assignment should be documented. Immunization status must be tested with a single- antigen bead array (i.e Luminex- SAB). Data should be transferred directly with raw data to the database so accurate handling of allele specific antibodies or antibodies against certain DQA1/DQB1 heterodimers can properly be identified. There must be a mechanism for the responsible immunologist to remove or add other specificities based of previous immunization history or previous transplants. The database used for matching should be able to indicate if donors are carrying alleles that are not tested for among the SAB in the recipients. In this case the matching should be on a generic level but be clearly indicated as such. Antibody testing should be repeated quarterly ( HLA and anti A and B) or after potential senzitizing events (e.g blood transfusion) All recipients included in the STEP programme needs to be de-activated on the kidney waiting list during a scheduled run and until the resulting exchanges are decided/planned. During the time period in between decision and transplantation, the scheduled exchange recipients will remain de-activated. Prioritization rules: The Matching Algorithm: In the start of the program, only paired exchanges (2-way-exchanges) will be performed. When the program is implemented and the Nordic Kidney Transplant Group decides so, 3-way-exchanges, chains and altruistic donors will be allowed in the matching algorithm. The algorithm will prioritize:

1. The number of transplanted patients 2. Short cycles (initially only 2-way exchanges will be performed) 3. Low match probability 4. Compatible blood groups, the number of ABO-incompatible transplants should be minimized in each matchrun Note also that: a) In the start of the program, all cycles will be of length 2 (i.e., only 2- way-exchanges will be performed). Therefore, point 2., from the above, will not be relevant, and a priority matching with only 2-wayexchanges will be performed. b) In case a patient has several potential donors, the donor will be selected based on points 1-4, where point 4 is interpreted as the sum of match probabilities of all matched pairs for a given set of donors.

Information to patients and physicians Benefits of joining a kidney paired donation program For recipients: They could receive a living donor transplant. Kidneys from live donors last longer, on average, than kidneys from deceased donors. Participants may spend less time on dialysis; they may receive a transplant before starting dialysis. They may not have to wait as long for a transplant. For donors: You may help your family member/friend. It can be a rewarding experience as more families are helped by your donation. Risk of joining a kidney paired donation program For recipients: There is a limited possibility that the program will find a matching kidney for the recipient and a paired exchange actually will take place, especially when the recipient have a lot of antibodies. To enable a kidney exchange it can take some months to do a couple of match runs which are necessary to do to find matching pair.